01364nas a2200457   4500000000100000000000100001000000100002008004100003653001100044653005400055653006000109653001100169653000900180653002600189653000900215653008300224653006000307653004800367653001600415653002200431653001900453653002500472653001400497653002500511653001500536653001800551653001600569653001400585100001300599700001300612700001600625700001600641700001600657700002100673700001300694245015300707250001500860300001000875490000700885020001400892       2024                            d10aHumans10a*Warfarin/adverse effects/administration & dosage10a*Respiratory Tract Infections/drug therapy/epidemiology10aFemale10aMale10aRetrospective Studies10aAged10a*Anti-Bacterial Agents/adverse effects/administration & dosage/therapeutic use10a*Anticoagulants/adverse effects/administration & dosage10a*Hemorrhage/chemically induced/epidemiology10aMiddle Aged10aAged, 80 and over10aCohort Studies10aEngland/epidemiology10aIncidence10aAdministration, Oral10aantibiotic10aanticoagulant10ahaemorrhage10ainfection1 aH. Ahmed1 aN. Reeve1 aD. Farewell1 aF. Hamilton1 aM. Ponsford1 aJ. Hippisley-Cox1 aS. Noble00aRisk of bleeding amongst warfarin and direct oral anticoagulant users prescribed immediate antibiotics for respiratory tract infection: Cohort study  a2024/04/29  ae57940 v33  a1053-8569